|
RPTX | Repare Therapeutics Inc. |
|
|
RPTX | Repare Therapeutics Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 2.82 |
| Leverage | 14.38% |
| Market Cap | $ 53.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -84.1m |
| Margin | -821.67% |
Repair Therapeutics Inc., a precision oncology company, discovers and develops novel therapies using its synthetic lethality approach in Canada and the United States. The company is headquartered in Montral, Canada.